Literature DB >> 4870102

Effect of propranolol on elevated arterial blood pressure.

D W Richardson, J Freund, A S Gear, H P Mauck, L W Preston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4870102     DOI: 10.1161/01.cir.37.4.534

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  19 in total

1.  Haemodynamic effects of beta-adrenorecptor blockers in hypertension.

Authors:  B Ablad; B Ljung; R Sannerstedt
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  The clinical use of propranolol.

Authors:  A Bowyer
Journal:  Calif Med       Date:  1970-02

Review 3.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

4.  Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).

Authors:  I Persson; J Ulrich
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

5.  Propranolol in hypertension. Report on 158 patients treated up to one year.

Authors:  L Hansson; R Malmcrona; R Olander; L Rosenhall; A Westerlund; H Aberg; B Hood
Journal:  Klin Wochenschr       Date:  1972-04-01

6.  Controlled trial of oxprenolol and practolol in hypertension.

Authors:  A W Leishman; J L Thirkettle; B R Allen; R A Dixon
Journal:  Br Med J       Date:  1970-11-07

7.  Propranolol and polythiazide in treatment of hypertension.

Authors:  E T O'Brien; J MacKinnon
Journal:  Br Heart J       Date:  1972-10

8.  Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1982-01       Impact factor: 4.335

9.  Serum enzymes and propranolol.

Authors:  R Wilkinson; J A Luetscher; R H Goldman
Journal:  Br Med J       Date:  1971-05-01

10.  Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Authors:  M Motolese; G Muiesan; A Colombi
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.